332 related articles for article (PubMed ID: 16061667)
21. The a3 isoform vacuolar type H⁺-ATPase promotes distant metastasis in the mouse B16 melanoma cells.
Nishisho T; Hata K; Nakanishi M; Morita Y; Sun-Wada GH; Wada Y; Yasui N; Yoneda T
Mol Cancer Res; 2011 Jul; 9(7):845-55. PubMed ID: 21669964
[TBL] [Abstract][Full Text] [Related]
22. [LASS2/TMSG1 gene silencing promotes the invasiveness and metastatic of human prostatic carcinoma cells through increase in vacuolar ATPase activity].
Xu X; You J; Pei F
Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):177-83. PubMed ID: 24842017
[TBL] [Abstract][Full Text] [Related]
23. [Establishment of human hepatocellular carcinoma cell line with spontaneous pulmonary metastasis through in vivo selection].
Li Y; Tang Z; Ye S; Liu Y; Chen J; Xue Q; Huang X; Chen J; Bao W; Yang J; Gao D
Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):601-5. PubMed ID: 12133480
[TBL] [Abstract][Full Text] [Related]
24. Small interfering RNA targeting the subunit ATP6L of proton pump V-ATPase overcomes chemoresistance of breast cancer cells.
You H; Jin J; Shu H; Yu B; De Milito A; Lozupone F; Deng Y; Tang N; Yao G; Fais S; Gu J; Qin W
Cancer Lett; 2009 Jul; 280(1):110-9. PubMed ID: 19299075
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion.
Wu X; Fan J; Wang X; Zhou J; Qiu S; Yu Y; Liu Y; Tang Z
Biochem Biophys Res Commun; 2007 Apr; 355(4):866-71. PubMed ID: 17336272
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.
Sheng SL; Liu JJ; Dai YH; Sun XG; Xiong XP; Huang G
FEBS J; 2012 Oct; 279(20):3898-910. PubMed ID: 22897481
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.
Zhao J; Dong L; Lu B; Wu G; Xu D; Chen J; Li K; Tong X; Dai J; Yao S; Wu M; Guo Y
Gastroenterology; 2008 Sep; 135(3):956-68. PubMed ID: 18555021
[TBL] [Abstract][Full Text] [Related]
28. EphA1 receptor silencing by small interfering RNA has antiangiogenic and antitumor efficacy in hepatocellular carcinoma.
Chen G; Wang Y; Zhou M; Shi H; Yu Z; Zhu Y; Yu F
Oncol Rep; 2010 Feb; 23(2):563-70. PubMed ID: 20043122
[TBL] [Abstract][Full Text] [Related]
29. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
30. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of BDNF suppressed invasion of HepG2 and HCCLM3 cells, a mechanism associated with inactivation of RhoA or Rac1 and actin skeleton disorganization.
Guo D; Sun W; Zhu L; Zhang H; Hou X; Liang J; Jiang X; Liu C
APMIS; 2012 Jun; 120(6):469-76. PubMed ID: 22583359
[TBL] [Abstract][Full Text] [Related]
32. BetaIg-h3 is involved in the HAb18G/CD147-mediated metastasis process in human hepatoma cells.
Tang J; Zhou HW; Jiang JL; Yang XM; Li Y; Zhang HX; Chen ZN; Guo WP
Exp Biol Med (Maywood); 2007 Mar; 232(3):344-52. PubMed ID: 17327467
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
[TBL] [Abstract][Full Text] [Related]
34. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
[TBL] [Abstract][Full Text] [Related]
35. HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma.
Xu J; Xu HY; Zhang Q; Song F; Jiang JL; Yang XM; Mi L; Wen N; Tian R; Wang L; Yao H; Feng Q; Zhang Y; Xing JL; Zhu P; Chen ZN
Mol Cancer Res; 2007 Jun; 5(6):605-14. PubMed ID: 17579119
[TBL] [Abstract][Full Text] [Related]
36. [Inhibitory effect of RNAi targeting human telomerase reverse transcriptase against human hepatocellular carcinoma cells].
Li H; Wang XL; Yang Y; Zhang J; Wang GS; Jiang N; Chen GH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1323-6. PubMed ID: 18753050
[TBL] [Abstract][Full Text] [Related]
37. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo.
He XW; Liu T; Chen YX; Cheng DJ; Li XR; Xiao Y; Feng YL
Cancer Gene Ther; 2008 Mar; 15(3):193-202. PubMed ID: 18202713
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis.
Mak GW; Chan MM; Leong VY; Lee JM; Yau TO; Ng IO; Ching YP
Cancer Res; 2011 Apr; 71(8):2949-58. PubMed ID: 21385901
[TBL] [Abstract][Full Text] [Related]
39. Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma.
Sun BS; Dong QZ; Ye QH; Sun HJ; Jia HL; Zhu XQ; Liu DY; Chen J; Xue Q; Zhou HJ; Ren N; Qin LX
Hepatology; 2008 Dec; 48(6):1834-42. PubMed ID: 18972404
[TBL] [Abstract][Full Text] [Related]
40. A small interfering RNA targeting osteopontin as gastric cancer therapeutics.
Gong M; Lu Z; Fang G; Bi J; Xue X
Cancer Lett; 2008 Dec; 272(1):148-59. PubMed ID: 18694621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]